AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2014
Dec 9, 2014
30016_dirs_2014-12-09_8869c894-14f4-4b3f-9045-200ac804c3aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-12-05
Reporting Person: MAZELSKY JAY (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-05 | Common Stock | M | 481 | — | Acquired | 2521 | Direct |
| 2014-12-05 | Common Stock | F | 155 | $148.62 | Disposed | 2366 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-05 | Restricted Stock Unit | $ | M | 481 | Disposed | Common Stock (481) | Direct |
Footnotes
F1: Includes 45 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 09/30/2014.
F2: Represents restricted stock units previously granted on 12/05/2013 that have vested. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date of the date of grant (12/05/2014).
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 26